Michelle Friedman-Yakoobian, Ph.D., is the clinic director of the Center for Early Detection, Assessment and Response to Risk Clinic for youth ages 12-30 who are showing signs of clinical high risk (possible prodrome) for psychosis.  Her program of research has focused on the development and implementation of effective psychosocial interventions for individuals experiencing psychosis (or signs of risk) and their families. These have included family interventions, cognitive remediation, school and work coaching, and acceptance and commitment therapy. Psychology interns with interest and background in these areas may have opportunities for contributing to data analysis and development of poster and paper presentations.  

Emily Kline Ph.D. conducts research that focuses on expanding access to and engagement with mental health services among youth and young adults with emerging mental illnesses. This includes projects investigating rates of screening for psychosis among community mental health practitioners, assessing treatment outcomes in real-world first episode psychosis treatment programs, and training family members of individuals with mental illnesses in motivational interviewing-style communication strategies. Dr. Kline supervises a post-doctoral fellowship focusing on development and dissemination of evidence-based practices for first episode psychosis, and is also interested in working with interns who share her research interests.  

Raquelle Mesholam-Gately, Ph.D. has a research program that is broadly focused on better understanding and improving neurocognitive and reward-related impairments in schizophrenia-spectrum illnesses (including cognitive remediation efforts), as well as to the enhancement of mental health research through collaboration with individuals who have lived experience with mental illness (through her direction of a Consumer Advisory Board (CAB) at MMHC). Examples of research opportunities include contributing to a manuscript related to the relationship of hedonic experience to improvement in cognitive remediation, participating in twice monthly CAB meetings,  co-authoring a manuscript on the relationship between therapeutic alliance and quality of life (based on a CAB study, which used questionnaires the group developed), participating in a CAB project to potentially rename schizophrenia, which involves dissemination of a “renaming survey” the group developed and eventual writing of papers on our findings.  

William Stone, Ph.D., ABPP-CN, is an associate professor of psychology in the Harvard Medical School Department of Psychiatry who directs the Fellowship in Clinical Neuropsychology at Beth Israel Deaconess Medical Center (BIDMC) and the Massachusetts Mental Health Center (MMHC). He also directs the neuropsychology training and clinical services programs, and the Psychosis Research Program, both at MMHC. His research focuses on the identification and amelioration of risk factors for psychosis, with an emphasis on cognition. He is the principal investigator on two longitudinal studies identifying prodromal syndromes for psychosis and is involved in the effort to develop and improve individualized ‘risk calculators’ for psychosis”. Dr. Stone is also an investigator on a study in Ningxia, China, that is assessing relationships between cognitive performance and duration of untreated psychosis in a unique sample of community dwelling, rural Chinese subjects who went untreated for periods of up to 58 years. Research opportunities include data analysis, professional presentations and co-authoring of manuscripts for publication.  

Michelle L. West, Ph.D., is a licensed psychologist and assistant director of the CEDAR Clinic, a specialty clinic for young people showing signs of risk for psychosis. Dr. West supervises referrals to the center, conducts individual and family therapy, completes diagnostic and psychosis risk evaluations and consultations with young adults and their families, supervises trainees (doctoral-level psychology trainees, research assistants, and undergraduate volunteers), and manages clinic assessment data. In addition, Dr. West does outreach presentations to raise awareness about new advances in early detection and treatment of early signs of psychosis. Her ongoing research involvements include several projects focused on understanding risk for psychosis, including as the project director of a large, multi-site study (“NAPLS”). Her clinical and research interests include diagnosis and treatment with complex clinical presentations, cognitive behavioral therapy for psychosis (CBT-p), dialectical behavioral therapy (DBT), and assessment/collaborative management of suicide and violence risk.

Shirley Yen, Ph.D., is the Director of Clinical Psychology Training Program and has research based at both MMHC and Brown University. Her research focuses on identifying risk factors and developing interventions for suicidal behaviors in adolescents and adults. As an investigator on prospective, longitudinal studies of youth with bipolar disorder, adults with personality disorders, and suicidal adolescents, Dr. Yen has examined prospective predictors of suicidal behavior. She has also been the principal investigator of three adjunctive transdiagnostic interventions for suicidal adolescents. She is currently piloting an acceptance based intervention for youth with psychosis, a positive affect intervention for young adult outpatients which utilizes test messaging to enhance skills practice, and a yoga intervention for depressed adolescents. She is also conducting research to examine mechanisms of suicide risk in sexual minority adolescents. Research opportunities include co-authoring manuscripts on one of the projects described above.